HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.

AbstractOBJECTIVE:
We undertook a non-targeted lipidomics analysis of post-mortem cerebrospinal fluid (CSF), frontal cortex grey matter, and subjacent white matter to define potential biomarkers that distinguish cognitively intact subjects from those with incipient or established dementia. Our objective was to increase our understanding of the role of brain lipids in pathophysiology of aging and age-related cognitive impairment.
METHODS:
Levels of 650 individual lipids, across 26 lipid subclasses, were measured utilising a high-resolution mass spectrometric analysis platform.
RESULTS:
Monoacylglycerols (MAG), diacylglycerols (DAG), and the very-long-chain fatty acid 26:0 were elevated in the grey matter of the mild cognitive impairment (MCI) and old dementia (OD) cohorts. Ethanolamine plasmalogens (PlsEtn) were decreased in the grey matter of the young dementia (YD) and OD cohorts while and phosphatidylethanolamines (PtdEth) were lower in the MCI, YD and OD cohorts. In the white matter, decrements in sulphatide levels were detected in the YD group, DAG levels were elevated in the MCI group, and MAG levels were increased in the YD and OD groups.
CONCLUSION:
The parallel changes in grey matter MAGs and DAGs in the MCI and OD groups suggest that these two cohorts may have a similar underlying pathophysiology; consistent with this, MCI subjects were more similar in age to OD than to YD subjects. While PlsEtn and phosphatidylethanolamine were decreased in the YD and OD groups they were unaltered in the MCI group indicating that alterations in plasmalogen synthesis are unlikely to represent an initiating event in the transition from MCI to dementia.
AuthorsPaul L Wood, Brooke L Barnette, Jeffrey A Kaye, Joseph F Quinn, Randall L Woltjer
JournalActa neuropsychiatrica (Acta Neuropsychiatr) Vol. 27 Issue 5 Pg. 270-8 (Oct 2015) ISSN: 1601-5215 [Electronic] England
PMID25858158 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Diglycerides
  • Monoglycerides
  • Plasmalogens
  • phosphatidal ethanolamines
  • Docosahexaenoic Acids
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (cerebrospinal fluid, metabolism, pathology)
  • Biomarkers (cerebrospinal fluid, metabolism)
  • Brain (metabolism)
  • Cognitive Dysfunction (cerebrospinal fluid, metabolism, pathology)
  • Dementia (metabolism, pathology)
  • Diagnosis
  • Diglycerides (cerebrospinal fluid, metabolism)
  • Docosahexaenoic Acids (cerebrospinal fluid, metabolism)
  • Female
  • Frontal Lobe (metabolism)
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Male
  • Monoglycerides (cerebrospinal fluid, metabolism)
  • Neuropsychological Tests
  • Plasmalogens (cerebrospinal fluid, metabolism)
  • White Matter (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: